Resultado de búsqueda
Hace 2 días · The COVID-19 mRNA vaccines from Moderna and Pfizer–BioNTech have efficacy rates of 90 to 95 percent [citation needed]. Prior mRNA, drug trials on pathogens other than COVID-19 were not effective and had to be abandoned in the early phases of trials.
- SARS-related coronavirus
The SARS-related coronavirus was one of several viruses...
- SARS-related coronavirus
Hace 1 día · Pfizer, the company behind the development and commercialization of the Comirnaty COVID-19 vaccine in partnership with BioNTech, was the top-selling company in the vaccines market (Fig. 1b), with ...
Hace 4 días · SARS-CoV-2 is a positive-sense single-stranded RNA virus. It is contagious in humans and is the cause of the coronavirus disease 2019 (COVID-19). Latest Research and Reviews. The...
Hace 5 días · The global public health emergency was declared over in May 2023 by the WHO, but infections with variants of SARS-CoV2 continue to evolve and cause infections worldwide. (1) Besides public health measures, developing, approving, and implementing vaccines against SARS-CoV2 have helped mitigate and end the pandemic.
Hace 5 días · Four years on from the pandemic, in the global north, vaccines remain the jewel in the crown of the Covid-19 response. Yet for some pandemic scientists, there was a missing piece in our outbreak ...
Hace 8 horas · COVID-19 vaccines, which became available in late 2020, are highly effective in protecting against severe illness and in limiting the spread of the disease; immunity can be further bolstered through subsequent booster doses of vaccine.
